Equities

Qingdao Haier Biomedical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Qingdao Haier Biomedical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)32.90
  • Today's Change-0.05 / -0.15%
  • Shares traded1.65m
  • 1 Year change+0.67%
  • Beta1.5033
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Qingdao Haier Biomedical Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of biomedical low-temperature storage products. The Company's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The Company's products are sold to domestic and overseas markets.

  • Revenue in CNY (TTM)2.26bn
  • Net income in CNY255.88m
  • Incorporated2005
  • Employees2.81k
  • Location
    Qingdao Haier Biomedical Co LtdNo. 280 Fengyuan Road, High-tech ZoneQINGDAO 266114ChinaCHN
  • Phone+86 53 288935566
  • Fax+86 53 288936010
  • Websitehttps://www.haierbiomedical.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sino Medical Sciences Technology Inc504.11m29.36m9.37bn691.00317.6510.36--18.590.07060.07061.212.170.3851.6342.71729,533.101.69-5.652.05-6.4563.9263.654.40-21.721.712.660.2102--33.641.03103.78-55.92-17.21--
Shinva Medical Instrument Co Ltd9.58bn508.92m9.39bn8.14k18.501.20--0.98070.8370.83715.7812.910.62862.204.501,177,051.003.304.126.278.9724.4625.095.245.610.8863--0.12421.150.08742.715.75-4.2914.3026.58
Shanghai Runda Medical Technology Co Ltd7.40bn-157.84m9.77bn3.14k--2.34--1.32-0.2609-0.260912.466.920.52373.681.462,360,202.00-0.55773.81-1.4910.1921.9826.78-1.065.440.97231.160.560515.85-9.133.34-79.77-29.14-4.52--
Shanghai Haohai Biological Tech Co Ltd2.52bn384.21m9.95bn2.16k28.371.91--3.951.651.6510.8324.490.35121.537.841,169,728.004.944.585.965.2669.1370.3914.0714.673.24--0.065642.371.6410.951.042.55-1.8614.87
Qingdao Haier Biomedical Co Ltd2.26bn255.88m10.43bn2.81k40.462.42--4.610.81440.81447.2113.640.40084.315.12806,199.104.6810.875.9214.1245.3149.2111.6724.082.41--0.020528.140.128817.67-9.7115.03-5.5321.16
Xiangyu Medical Co Ltd773.93m73.51m10.69bn2.34k139.565.28--13.820.47890.47895.0712.670.25481.0111.40330,597.702.358.543.2610.1765.9866.789.2228.370.9871--0.238732.49-0.171711.71-54.68-4.4183.55--
Shanghai Microport EP MedTech Co Ltd458.70m52.26m11.05bn500.00211.536.17--24.100.1110.1110.97473.810.23951.336.85917,403.002.730.90842.910.957958.2464.9511.394.0910.17--0.00320.0025.5128.61815.36--35.67--
Beijing Wandong Medical Technolgy Co Ltd1.62bn14.41m11.26bn1.19k960.982.40--6.950.01670.01672.266.660.29372.732.991,360,016.000.26234.510.3045.2131.5942.820.893314.914.80--0.003943.2523.269.18-16.54-1.40-1.3921.06
TINAVI Medical Technologies Co Ltd274.20m-159.01m11.33bn307.00--9.07--41.31-0.3493-0.34930.60352.740.16732.187.63893,155.40-10.37-8.02-11.54-9.1670.0969.64-62.01-63.512.94-15.750.1408---14.85-4.8722.54--12.71--
Sansure Biotech Inc1.67bn271.49m11.48bn2.35k44.751.61--6.870.44270.44272.4512.310.18521.042.46711,687.902.5021.182.8124.3773.7068.6013.4940.514.49--0.171625.7444.7831.89-24.2347.5065.28--
Eyebright Medical Technlgy (Bjng) Co Ltd1.48bn360.97m11.65bn2.29k31.984.14--7.871.881.887.7114.530.40481.893.34644,799.409.9010.5011.5412.0462.9175.1324.4531.923.2824.660.175320.1148.2448.5127.7742.2518.40--
Data as of Feb 12 2026. Currency figures normalised to Qingdao Haier Biomedical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

8.39%Per cent of shares held by top holders
HolderShares% Held
Schroder Investment Management (Hong Kong) Ltd.as of 31 Dec 20259.83m3.09%
Hwabao WP Fund Management Co., Ltd.as of 14 Aug 20245.21m1.64%
China Asset Management Co., Ltd.as of 30 Jun 20252.22m0.70%
China Southern Asset Management Co., Ltd.as of 30 Jun 20251.90m0.60%
GF Fund Management Co., Ltd.as of 30 Jun 20251.88m0.59%
Bosera Asset Management Co., Ltd.as of 30 Jun 20251.42m0.45%
Penghua Fund Management Co., Ltd.as of 30 Jun 20251.31m0.41%
China Universal Asset Management Co., Ltd.as of 30 Jun 20251.06m0.33%
Harding Loevner LPas of 30 Sep 2025924.70k0.29%
Schroder Investment Management (Singapore) Ltd.as of 31 Jul 2025911.30k0.29%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.